tiprankstipranks
Burcon Nutrascience (TSE:BU)
TSX:BU
Want to see TSE:BU full AI Analyst Report?

Burcon Nutrascience (BU) Price & Analysis

76 Followers

BU Stock Chart & Stats

C$1.73
C$0.00(0.00%)
At close: 4:00 PM EST
C$1.73
C$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Proprietary IP & Product PlatformBurcon’s suite of proprietary extraction and purification technologies and multiple branded protein ingredients create a structural competitive advantage. The IP moat enables licensing, differentiated product sales, and blended solutions that support recurring revenue and barriers to entry for peers over the next 2–6 months.
Large & Diverse Customer FunnelA deep funnel of 200+ active projects and a high share of near-term growth from recurring buyers implies durable demand and higher conversion potential. This customer base can drive repeat ingredient volumes, shorten payback on commercialization investments, and underpin sustainable revenue expansion.
Cost Reductions Improving Operating LeverageMeaningful cuts to R&D and G&A improve near-term cash runway and operating leverage. If maintained alongside commercial scale-up, these structural cost efficiencies increase the probability of reaching cash-flow breakeven and sustaining margins as production volumes grow.
Bears Say
Deteriorated Balance SheetNegative equity and elevated leverage materially constrain financial flexibility and increase refinancing risk. Over the medium term this limits the company’s ability to invest in capacity or absorb shocks without dilutive financing or costly debt, pressuring strategic options and execution.
Weak Cash GenerationPersistent negative operating and free cash flow indicate the business remains dependent on external capital to fund operations. This structural cash burn increases execution risk, can force growth to be financing-constrained, and reduces margin resilience during scale-up phases.
Financing Dependence / Funding RiskNear-term liquidity relies on completing a convertible note tranche. Failure to secure the final tranche would materially impair planned capacity acceleration and commercialization timelines, creating execution risk and potential operational disruptions until alternative funding is secured.

Burcon Nutrascience News

BU FAQ

What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was C$1.51 and its highest was C$5.00 in the past 12 months.
    What is Burcon Nutrascience’s market cap?
    Burcon Nutrascience’s market cap is C$29.19M.
      When is Burcon Nutrascience’s upcoming earnings report date?
      Burcon Nutrascience’s upcoming earnings report date is Jul 01, 2026 which is in 17 days.
        How were Burcon Nutrascience’s earnings last quarter?
        Burcon Nutrascience released its earnings results on Feb 11, 2026. The company reported -C$0.28 earnings per share for the quarter, missing the consensus estimate of C$0 by -C$0.28.
          Is Burcon Nutrascience overvalued?
          According to Wall Street analysts Burcon Nutrascience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Burcon Nutrascience pay dividends?
            Burcon Nutrascience does not currently pay dividends.
            What is Burcon Nutrascience’s EPS estimate?
            Burcon Nutrascience’s EPS estimate is -0.1.
              How many shares outstanding does Burcon Nutrascience have?
              Burcon Nutrascience has 12,692,276 shares outstanding.
                What happened to Burcon Nutrascience’s price movement after its last earnings report?
                Burcon Nutrascience reported an EPS of -C$0.28 in its last earnings report, missing expectations of C$0. Following the earnings report the stock price went up 1.596%.
                  Which hedge fund is a major shareholder of Burcon Nutrascience?
                  Currently, no hedge funds are holding shares in TSE:BU
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Burcon Nutrascience

                    Burcon NutraScience Corporation, along with its associated entities, is a Canadian enterprise specializing in the development and commercialization of plant-derived proteins and functional ingredients for the food and beverage sectors. Its extensive product line features Peazazz, a versatile pea protein suitable for a range of applications including dairy alternatives, ready-to-drink and dry-blended beverages, snack bars, baked goods, and meat substitutes. Also derived from peas, Peazac and Peazac 850 are tailored for plant-based meat alternatives, ready-to-mix powders and drinks, dairy-free options, and nutritional bars, particularly valued for their neutral taste profile and moderate textural properties. Among its canola-based proteins is Puratein, an isolate frequently utilized in meat alternatives such as burgers and sausages, as well as nutrition bars. Supertein, a pale-hued canola protein powder, is incorporated into non-dairy frozen desserts, egg replacers, plant-based marshmallows, ready-to-mix beverages, whipped toppings, and plant-based snack bars. Additionally, Nutratein, a canola protein composed of globulin and albumin, finds utility in meat and egg alternatives, alongside various other functional plant-based foods. Further expanding its offerings are Nutratein-PS and Nutratein-TZ, custom blends featuring its Peazac pea protein, alongside CLARISOY, a soy protein employed across sports nutrition beverages, citrus and fruit-flavored drinks, lemonades, powdered beverage mixes, and diverse other food and dietary items. Finally, MeritPro stands as a unique nutritional protein blend, distinguished by being allergen-free, gluten-free, dairy-free, non-GMO, and vegan-friendly. Originally incorporated in 1998 as Burcon Capital Corp., the firm rebranded to Burcon NutraScience Corporation in October 1999. Its corporate headquarters are situated in Vancouver, Canada.

                    Burcon Nutrascience (BU) Earnings & Revenues

                    BU Earnings Call

                    Q3 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call presented multiple concrete operational and financial positives: strong quarter-over-quarter revenue acceleration (100% QoQ), meeting calendar 2025 guidance ($1.4M cumulative), sizable customer funnel (200+ projects), meaningful cost reductions (R&D down 44% YoY; G&A down 22% YoY), and near-term financing progress (first tranche $1.25M of up to $6.9M) with management affirming double-digit revenue growth and cash flow positivity by end of 2026. Counterbalancing these positives are the small absolute revenue base, dependence on the final tranche of financing, shareholder concerns about liquidity and stock price, reduced R&D spend, and the inherent execution risks behind forward-looking targets. Overall, the highlights significantly outweigh the lowlights, but continued execution and successful closing of financing remain critical.View all TSE:BU earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    DAVIDsTEA
                    Else Nutrition Holdings
                    Nepra Foods
                    Cult Food Science Corp.

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks